NanoImpact《纳米影响》（季刊）. NanoImpact is a multidisciplinary journal that focuses on nanosafety and micro- and nanoplastic research and areas related to the impacts of size-dependent processes on human and environmental systems. Materials of interest to NanoImpact include manufactured and incidental nanomaterials, including ultrafine particles, and micro- and nanoplastics.

Environmental Science: Nano《环境科学：纳米》（月刊）. Environmental Science: Nano is a comprehensive, high-impact source of peer-reviewed information on the design and demonstration of engineered nanomaterials for environment-based applications and on the interactions of engineered, natural, and incidental nanomaterials with biological and environmental systems.

JOURNAL OF NANOBIOTECHNOLOGY《纳米生物技术杂志》（季刊）. Journal of Nanobiotechnology is an open access peer-reviewed journal communicating scientific and technological advances in the fields of medicine and biology, with an emphasis in their interface with nanoscale sciences.

IEEE TRANSACTIONS ON NANOBIOSCIENCE《IEEE纳米生物科学汇刊》（季刊）. The IEEE Transactions on NanoBioscience reports on original, innovative and interdisciplinary work on all aspects of molecular systems, cellular systems, and tissues (including molecular electronics). Topics covered in the journal focus on a broad spectrum of aspects, both on foundations and on applications. Specifically, methods and techniques, experimental aspects, design and implementation, instrumentation and laboratory equipment, clinical aspects, hardware and software data acquisition and analysis and computer based modelling are covered.

Nanomedicine《纳米医学》（一年30期）. Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.